ID   GILX_HELHO              Reviewed;         230 AA.
AC   P43685; E2I6G2;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   21-SEP-2011, sequence version 2.
DT   12-AUG-2020, entry version 85.
DE   RecName: Full=Gilatoxin;
DE            Short=GTX;
DE            EC=3.4.21.-;
DE   AltName: Full=Kallikrein-2;
OS   Heloderma horridum horridum (Mexican beaded lizard).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Anguimorpha; Neoanguimorpha; Helodermatidae; Heloderma.
OX   NCBI_TaxID=8552;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom gland;
RX   PubMed=20631207; DOI=10.1074/mcp.m110.001370;
RA   Fry B.G., Winter K., Norman J.A., Roelants K., Nabuurs R.J., van Osch M.J.,
RA   Teeuwisse W.M., van der Weerd L., McNaughtan J.E., Kwok H.F., Scheib H.,
RA   Greisman L., Kochva E., Miller L.J., Gao F., Karas J., Scanlon D., Lin F.,
RA   Kuruppu S., Shaw C., Wong L., Hodgson W.C.;
RT   "Functional and structural diversification of the Anguimorpha lizard venom
RT   system.";
RL   Mol. Cell. Proteomics 9:2369-2390(2010).
RN   [2]
RP   PROTEIN SEQUENCE, FUNCTION, GLYCOSYLATION, AND TOXIC DOSE.
RC   TISSUE=Venom;
RX   PubMed=8408054;
RA   Utaisincharoen P., Mackessy S.P., Miller R.A., Tu A.T.;
RT   "Complete primary structure and biochemical properties of gilatoxin, a
RT   serine protease with kallikrein-like and angiotensin-degrading
RT   activities.";
RL   J. Biol. Chem. 268:21975-21983(1993).
RN   [3]
RP   PRELIMINARY PROTEIN SEQUENCE OF 1-37.
RC   TISSUE=Venom;
RX   PubMed=3395124; DOI=10.1016/0003-9861(88)90594-2;
RA   Nikai T., Imai K., Sugihara H., Tu A.T.;
RT   "Isolation and characterization of horridum toxin with arginine ester
RT   hydrolase activity from Heloderma horridum (beaded lizard) venom.";
RL   Arch. Biochem. Biophys. 264:270-280(1988).
CC   -!- FUNCTION: Has kallikrein-like activity, releases bradykinin from
CC       kininogen. Catalyzes the hydrolysis of various arginine ester
CC       substrates for trypsin and thrombin and degrades both angiotensin I and
CC       II by cleavage of the dipeptide Asp-Arg from the NH2-terminal end.
CC       Fibrinogen is also degraded but a fibrin clot is not produced. May have
CC       a potentiating effect on potent hemorrhagic toxins present in the
CC       venom. {ECO:0000269|PubMed:8408054}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the mandibular venom gland.
CC   -!- PTM: Extensively glycosylated, contains approximately 8 mol of
CC       monosaccharide per mol of toxin. {ECO:0000269|PubMed:8408054}.
CC   -!- TOXIC DOSE: LD(50) is 2.5 mg/kg of body weight by intravenous injection
CC       into mice. {ECO:0000269|PubMed:8408054}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   -!- CAUTION: There is a significant difference between sequences of
CC       PubMed:20631207 and PubMed:8408054. The sequence of PubMed:8408054 may
CC       contain multiple errors since its last cysteine is absent from all
CC       other lizard toxin sequences and an insertion of 6 amino acids is
CC       present that is missing in other varanid lizard kallikrein toxins.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HM437246; ADK55606.1; -; mRNA.
DR   PIR; A48598; A48598.
DR   SMR; P43685; -.
DR   MEROPS; S01.435; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 2.40.10.10; -; 2.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR043504; Peptidase_S1_PA_chymotrypsin.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Protease; Secreted; Serine protease; Toxin.
FT   CHAIN           1..230
FT                   /note="Gilatoxin"
FT                   /id="PRO_0000088723"
FT   DOMAIN          1..230
FT                   /note="Peptidase S1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   ACT_SITE        41
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        93
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        187
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        84
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        7..146
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        26..42
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        125..193
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        157..172
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   DISULFID        183..208
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00274"
FT   CONFLICT        26
FT                   /note="C -> W (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        33
FT                   /note="Q -> R (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        37
FT                   /note="V -> L (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        43..58
FT                   /note="FYLGELRIGLGVHNRR -> EELGPMKICFGMKNRN (in Ref. 2; AA
FT                   sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        63
FT                   /note="N -> D (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67..71
FT                   /note="RVSAR -> KVAAV (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80..94
FT                   /note="SIITNSSCSEYTDDI -> GTIYNCNYVNTVLMNNDLLKRELFP (in
FT                   Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        104..106
FT                   /note="EYT -> DYN (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        110
FT                   /note="R -> A (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        121
FT                   /note="E -> L (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        126..128
FT                   /note="TVM -> SVL (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        136
FT                   /note="P -> D (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        140..142
FT                   /note="YPA -> LPD (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="R -> N (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        151..152
FT                   /note="ML -> IF (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158..159
FT                   /note="EL -> QV (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        165..170
FT                   /note="NITDSV -> KFTNK (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        175..176
FT                   /note="TW -> VD (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        192..195
FT                   /note="ICRG -> VCDN (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        200
FT                   /note="I -> N (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="Missing (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207
FT                   /note="P -> N (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211..224
FT                   /note="PLEYGVYTKVISFL -> GEKYGYIKLIKFN (in Ref. 2; AA
FT                   sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        229
FT                   /note="S -> N (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230
FT                   /note="I -> IIQGGTTCP (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   230 AA;  25111 MW;  B5816AC9F2EB1484 CRC64;
     IIGGQECDET GHPWLALLHR SEGSTCSGVL LNQDWIVTAA HCFYLGELRI GLGVHNRRVL
     RGNEQVRVSA RKKCYPATAS IITNSSCSEY TDDIMLIKLD SSVEYTERVR PLSLPTSPAS
     EGAECTVMGW GTTTPPDVTY PAVPVCVRIE MLNNAVCELA RDLWNITDSV LCAGTWFGGK
     DSCKGDSGGP LICRGQLTGI VSWGGFPCEQ PLEYGVYTKV ISFLFWIQSI
//
